Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Schizophrenia: rTMS may improve auditory hallucinations

Key clinical point: In patients with schizophrenia, low frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) targeting the left temporoparietal cortex may reduce auditory hallucinations (AH).

Major finding: The rTMS group showed greater improvements in AH compared with the sham group (standardized mean difference, −0.27; 95% CI, −0.51 to −0.03; P = .03).

Study details: Meta-analysis of 11 studies that evaluated the effects of rTMS on AH in schizophrenia.

Disclosures: This work was supported by the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Support Program of the Youth Sanjin Scholars, the 136 Medical Rejuvenation Project of Shanxi Province, and the Multidisciplinary Team for Cognitive Impairment of Shanxi Science and Technology Innovation Training Team. The authors declared no conflicts of interest.

Citation:

Li J et al. Psychiatry Res. 2020 May 29. doi: 10.1016/j.psychres.2020.113141.